搜尋
Eyenovia Inc
EYEN添加自選
15.820USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
44.78M總市值
虧損本益比TTM
關於 Eyenovia Inc 公司
Eyenovia, Inc. 是一家商業階段的眼科製藥技術公司，正在開發基於其 Optejet 平臺的微劑量陣列打印療法。該公司專注於 Mydcombi（託吡卡胺+苯腎上腺素眼用噴霧劑）的商業化，用於治療散瞳，以及 0.05% 丙酸氯倍他索眼用混懸液，用於減輕眼科手術後的疼痛和炎症。其產品線包括 Mydcombi、丙酸氯倍他索和治療方案 MicroPine 和 MicroLine。Mydcombi 是託吡卡胺-苯腎上腺素的固定組合配方，用於在診斷程序中以及在需要短期瞳孔擴張的情況下誘導散瞳。MicroPine 是其用於治療進行性近視的局部療法，這是一種與眼球病理性軸向延長和鞏膜視網膜拉伸有關的疾病。 MicroLine 是該公司針對老花眼（一種與年齡相關的不可預防的晶狀體硬化）的在研藥物。
Eyenovia Inc簡介
公司代碼EYEN
公司名稱Eyenovia Inc
上市日期Jan 25, 2018
CEOMr. Michael M. Rowe
員工數量13
證券類型Ordinary Share
年結日Jan 25
公司地址295 Madison Ave Ste 2400
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編10017
電話18137669539
網址https://eyenovia.com/
公司代碼EYEN
上市日期Jan 25, 2018
CEOMr. Michael M. Rowe
Eyenovia Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Hyunsu Jung
Mr. Hyunsu Jung
Interim Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary
Interim Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary
1.50M
+0.01%
Mr. David Knox
Mr. David Knox
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
300.00K
--
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
56.71K
+1.31%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
56.30K
+1.41%
Mr. Happy David Walters
Mr. Happy David Walters
Director
Director
50.00K
--
Mr. Eric Ribner
Mr. Eric Ribner
Investor Relations
Investor Relations
--
--
Mr. Michael Geltzeiler
Mr. Michael Geltzeiler
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Hyunsu Jung
Mr. Hyunsu Jung
Interim Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary
Interim Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary
1.50M
+0.01%
Mr. David Knox
Mr. David Knox
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
300.00K
--
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
56.71K
+1.31%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
56.30K
+1.41%
Mr. Happy David Walters
Mr. Happy David Walters
Director
Director
50.00K
--
Mr. Eric Ribner
Mr. Eric Ribner
Investor Relations
Investor Relations
--
--
常見問題
Eyenovia Inc的前五大股東是誰？
Eyenovia Inc的前五大股東如下：Mr. Hyunsu Jung
有多少機構持有Eyenovia Inc(EYEN)的股份？
截至2026Q1，共有136家機構持有Eyenovia Inc的股份，合計持有的股份價值約為1.29M，占公司總股份的9.10% 。與2025Q4相比，機構持股有所增加，增幅為237088.00。